SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin incorporates wholly owned subsidiary in Thailand

18 Apr 2026 Evaluate

Lupin has incorporated a wholly owned subsidiary in Thailand in the name and style ‘Lupin (Thailand)’ on April 17, 2026. Lupin (Thailand) shall be engaged to import, market, promote, distribute and sell pharmaceutical products in Thailand.

Lupin (Thailand) has been incorporated with a registered and paid up capital of 3,000,000 Baht divided into 600,000 Shares of par value of 5 Baht each.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Lupin Share Price

2296.10 -44.10 (-1.88%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×